Alimera Sciences (ALIM) Market Cap

Price: $5.54
Market Cap: $301.29M
Avg Volume: 866.83K
Country: US
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: 1.245
52W Range: $2.606-5.65
Website: Alimera Sciences

Market Cap Overview

Market Cap

$301.29M

Share Price

$5.54

Shares Outstanding

54.38M


What is Alimera Sciences's Market Cap?

Alimera Sciences's current Market Cap as of today is $301.29M.

Understanding Market Capitalization

Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.

  • It provides a straightforward method of gauging a company's size.
  • Market Cap can be used to compare companies within the same industry.

How is Market Cap calculated?

Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:

Market Cap = Current Share Price × Total Shares Outstanding

In the case of Alimera Sciences, the market cap is calculated as $5.54 x 54.38M shares = $301.29M.

As a Small Cap company, Alimera Sciences is a smaller company that may offer growth opportunities.

Alimera Sciences Historical Market Cap

$320.00M$320.00M$240.00M$240.00M$160.00M$160.00M$80.00M$80.00M$0.00$0.00Market CapJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '24
Download SVG
Download PNG
Download CSV

Alimera Sciences Market Cap vs Enterprise Value

Understanding Market Cap vs. Enterprise Value

While market cap represents the equity value of Alimera Sciences, enterprise value provides a more complete picture of the company's total value by including debt and cash:

Market Cap
Enterprise Value
$450.00M$450.00M$360.00M$360.00M$270.00M$270.00M$180.00M$180.00M$90.00M$90.00M$0.00$0.00Value20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '24
Download SVG
Download PNG
Download CSV

Enterprise Value = Market Cap + Total Debt - Cash and Equivalents

Alimera Sciences's enterprise value as of June 30, 2024 (Q2 2024) is calculated as:

  • Market Cap: $301.29M
  • Total Debt: $72.16M
  • Cash and Equivalents: $10.86M
  • Enterprise Value: $361.49M

The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A higher enterprise value suggests significant debt levels.

Alimera Sciences Annual Market Cap History

Year Market Cap Change
2025 $301.29M 172.84%
2023 $110.43M 482.38%
2022 $18.96M -43.96%
2021 $33.83M 56.66%
2020 $21.60M -40.27%
2019 $36.16M -28.07%
2018 $50.27M -43.58%
2017 $89.10M 56.25%
2016 $57.03M -46.99%
2015 $107.57M -51.94%
2014 $223.80M 50.78%
2013 $148.42M 200.48%
2012 $49.40M 26.00%
2011 $39.20M -82.96%
2010 $230.10M 1278.60%
2009 $16.69M -6.28%
2008 $17.81M 0.00%
2007 $17.81M 0.00%
2006 $17.81M N/A

Frequently Asked Questions

Alimera Sciences's current market capitalization is $301.29M. This makes it a Small Cap company, calculated by multiplying its current stock price of $5.54 by 54.38M outstanding shares.

Alimera Sciences's enterprise value is $361.49M. This is calculated by adding total debt ($72.16M) to market cap and subtracting cash and equivalents ($10.86M). Enterprise value provides a more complete picture of the company's total value by considering both its debt and cash positions.

Alimera Sciences has 54.38M shares outstanding. This number represents the total number of shares currently held by all shareholders, including company insiders, institutional investors, and the public.

Alimera Sciences is classified as a Small Cap company. Small-cap companies are smaller companies with market caps between $300 million and $2 billion.

Alimera Sciences's market cap is calculated by multiplying its current stock price ($5.54) by its total number of outstanding shares (54.38M). This calculation represents the total market value of all the company's outstanding shares at the current market price.

Related Metrics

Explore detailed financial metrics and analysis for ALIM.